نتایج جستجو برای: melanoma inhibitor of apoptosis ml

تعداد نتایج: 21218902  

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2001
A Bhoumik V Ivanov Z Ronai

Activating transcription factor 2 (ATF2) and its kinase, p38, play an important role in the resistance of melanoma to radiation and chemotherapy. Whereas ATF2 up-regulates the expression of tumor necrosis factor alpha, which serves as a survival factor in late-stage melanoma cells, p38 attenuates Fas expression via inhibition of nuclear factor-kappaB. We investigated whether ATF2-derived peptid...

2015
Andreas Koch Sven Arke Lang Peter Johannes Wild Susanne Gantner Abdo Mahli Gerrit Spanier Mark Berneburg Martina Müller Anja Katrin Bosserhoff Claus Hellerbrand

The glucose transporter isoform 1 (GLUT1; SLC2A1) is a key rate-limiting factor in the transport of glucose into cancer cells. Enhanced GLUT1 expression and accelerated glycolysis have been found to promote aggressive growth in a range of tumor entities. However, it was unknown whether GLUT1 directly impacts metastasis. Here, we aimed at analyzing the expression and function of GLUT1 in maligna...

2013
Brijal M. Desai Jessie Villanueva Thierry-Thien K. Nguyen Mercedes Lioni Min Xiao Jun Kong Clemens Krepler Adina Vultur Keith T. Flaherty Katherine L. Nathanson Keiran S. M. Smalley Meenhard Herlyn

Although cyclin dependent kinase (CDK)-2 is known to be dispensable for the growth of most tumors, it is thought to be important for the proliferation of melanoma cells, where its expression is controlled by the melanocyte-lineage specific transcription factor MITF. Treatment of a panel of melanoma cells with the CDK inhibitor dinaciclib led to a concentration-dependent inhibition of growth und...

Journal: :Molecular cancer therapeutics 2004
Jian-Zhong Qin Lawrence Stennett Patricia Bacon Barbara Bodner Mary J C Hendrix Richard E B Seftor Elisabeth A Seftor Naira V Margaryan Pamela M Pollock Amy Curtis Jeffrey M Trent Frank Bennett Lucio Miele Brian J Nickoloff

Once melanoma metastasizes, no effective treatment modalities prolong survival in most patients. This notorious refractoriness to therapy challenges investigators to identify agents that overcome melanoma resistance to apoptosis. Whereas many survival pathways contribute to the death-defying phenotype in melanoma, a defect in apoptotic machinery previously highlighted inactivation of Apaf-1, an...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2011
Chen Chen Jiang Fritz Lai Rick F Thorne Fan Yang Hao Liu Peter Hersey Xu Dong Zhang

PURPOSE To examine mechanisms that determine long-term responses of B-RAF(V600E) melanoma cells to B-RAF inhibitors. EXPERIMENTAL DESIGN B-RAF(V600E) melanoma cells were exposed to the B-RAF inhibitor PLX4720 for prolonged periods to select for cells resistant to apoptosis induced by the inhibitor. The resultant cells were analyzed for activation of extracellular signal regulated kinase (ERK)...

Journal: :Molecules 2016
Raquel T Lima Diana Sousa Ana M Paiva Andreia Palmeira João Barbosa Madalena Pedro Madalena M Pinto Emília Sousa M Helena Vasconcelos

(1) Background: Our previous studies unveiled the hit thioxanthone TXA1 as an inhibitor of P-glycoprotein (drug efflux pump) and of human tumor cells growth, namely of melanoma cells. Since TXA1 is structurally similar to lucanthone (an autophagy inhibitor and apoptosis inducer) and to N10-substituted phenoxazines (isosteres of thioxanthones, and autophagy inducers), this study aimed at further...

حسن, زهیر, دلیمی, عبدالحسین, شریفی, زهره, غفاری‏فر, فاطمه, معروفی, یحیی,

Background and purpose: Leishmania is flagellated protozoa and causative agent of leishmaniosis. It is one of the main public health problems in developing countries. Cantharidin is terpenoid component that exists in Meloidae and Oedemeridae beetles. Cantharidin is vesicant and could induce apoptosis in cancerous cells. This study was performed to determine the role of cantharidin in inducing a...

Journal: :The American journal of the medical sciences 2013
Seong Joon Park Seung-Woo Hong Jai-Hee Moon Dong-Hoon Jin Jin-Sun Kim Chang-Kyu Lee Kyu-pyo Kim Yong Sang Hong Eun Kyung Choi Jung Shin Lee Jae-Lyun Lee Tae Won Kim

BACKGROUND Although inhibitors of the proto-oncogene BRAF have shown excellent antitumor activity against malignant melanoma, their efficacy is limited by the development of acquired drug resistance, a process in which reactivation of MAP kinase (MEK) is known to play an important role. In this study, we evaluated the efficacy of AS703026, a new MEK inhibitor, in BRAF inhibitor-resistant melano...

E. Amini, J. Baharara, Kh. Nezhad Shahrokhabadi, N. Nikdel,

Skin cancer has been reported as a contemporary malignant cancer. Here, anti-cancer effects of sea cucumber extract (SCE) from Holothuria arenicola have been examined on melanoma cells and compared with imidazole carboxamide (Dacarbazine) as a chemotherapy medication against melanoma and Hodgkin's lymphoma. MTT assay and morphological analysis were performed to evaluate cytotoxic effects of H. ...

Journal: :Cancer research 2016
Barbara Herkert Audrey Kauffmann Sandra Mollé Christian Schnell Thomas Ferrat Hans Voshol Janina Juengert Hélène Erasimus Grégory Marszalek Malika Kazic-Legueux Eric Billy David Ruddy Mark Stump Daniel Guthy Mitko Ristov Keith Calkins Sauveur-Michel Maira William R Sellers Francesco Hofmann Michael N Hall Saskia M Brachmann

The introduction of MAPK pathway inhibitors paved the road for significant advancements in the treatment of BRAF-mutant (BRAF(MUT)) melanoma. However, even BRAF/MEK inhibitor combination therapy has failed to offer a curative treatment option, most likely because these pathways constitute a codependent signaling network. Concomitant PTEN loss of function (PTEN(LOF)) occurs in approximately 40% ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید